InnoPharmax Inc. (4172.TWO)

TWD 15.75

(0.32%)

Operating Income Summary of InnoPharmax Inc.

  • InnoPharmax Inc.'s latest annual operating income in 2023 was -64.83 Million TWD , up 31.87% from previous year.
  • InnoPharmax Inc.'s latest quarterly operating income in 2024 Q2 was -20.31 Million TWD , down 0.0% from previous quarter.
  • InnoPharmax Inc. reported an annual operating income of -103.42 Million TWD in 2022, down -10.73% from previous year.
  • InnoPharmax Inc. reported an annual operating income of -93.4 Million TWD in 2021, down -125.7% from previous year.
  • InnoPharmax Inc. reported a quarterly operating income of -20.31 Million TWD for 2024 Q2, down 0.0% from previous quarter.
  • InnoPharmax Inc. reported a quarterly operating income of -12.45 Million TWD for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Income Chart of InnoPharmax Inc. (2023 - 2019)

Historical Annual Operating Income of InnoPharmax Inc. (2023 - 2019)

Year Operating Income Operating Income Growth
2023 -64.83 Million TWD 31.87%
2022 -103.42 Million TWD -10.73%
2021 -93.4 Million TWD -125.7%
2020 -41.38 Million TWD 44.78%
2019 -74.94 Million TWD 0.0%

Peer Operating Income Comparison of InnoPharmax Inc.

Name Operating Income Operating Income Difference
Allied Biotech Corporation 88.71 Million TWD 173.088%
GeneFerm Biotechnology Co., Ltd. 153.56 Million TWD 142.223%
Easywell Biomedicals, Inc. -162.73 Million TWD 60.157%
TTY Biopharm Company Limited 1.37 Billion TWD 104.724%
Synmosa Biopharma Corporation 614.74 Million TWD 110.547%
Orient EuroPharma Co., Ltd. 84.55 Million TWD 176.684%
Center Laboratories, Inc. -79.26 Million TWD 18.2%
Tien Liang BioTech Co., Ltd. 20.43 Million TWD 417.278%
Orient Pharma Co., Ltd. 27.75 Million TWD 333.629%
Johnson Chemical Pharmaceutical Works Co., Ltd. 105.57 Million TWD 161.417%
Excelsior Biopharma Inc. -81.12 Million TWD 20.078%
DV Biomed Co., Ltd. 173.54 Million TWD 137.361%
Foresee Pharmaceuticals Co., Ltd. -1 Billion TWD 93.565%
Handa Pharmaceuticals, Inc. 695.79 Million TWD 109.319%
UniPharma Co., Ltd. -27.3 Million TWD -137.462%
Anxo Pharmaceutical Co., Ltd. 53.15 Million TWD 221.986%
Alar Pharmaceuticals Inc. 385.52 Million TWD 116.818%
Winston Medical Supply Co., Ltd. 196.1 Million TWD 133.064%
Mercury Biopharmaceutical Corporation -45.69 Million TWD -41.911%
Bioray Biotech Co., Ltd -19.33 Million TWD -235.415%
TSH Biopharm Corporation Limited 63.63 Million TWD 201.9%